These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20170007)
1. [Efficacy of intradermal regimen using Japanese rabies vaccine for pre-exposure prophylaxis]. Shiota S; Ahmed K; Mifune K; Nishizono A Kansenshogaku Zasshi; 2010 Jan; 84(1):9-13. PubMed ID: 20170007 [TBL] [Abstract][Full Text] [Related]
2. A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization. Shiota S; Khawplod P; Ahmed K; Mifune K; Nishizono A Vaccine; 2008 Nov; 26(50):6441-4. PubMed ID: 18804510 [TBL] [Abstract][Full Text] [Related]
3. [WHO recommended pre-exposure prophylaxis for rabies using Japanese rabies vaccine]. Yanagisawa N; Takayama N; Suganuma A Kansenshogaku Zasshi; 2008 Sep; 82(5):441-4. PubMed ID: 18975587 [TBL] [Abstract][Full Text] [Related]
4. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults. Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782 [TBL] [Abstract][Full Text] [Related]
5. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
7. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of intradermal vaccination of Japanese rabies vaccine for preexposure immunization following WHO recommendation. Yanagisawa N; Takayama N; Mannen K; Nakayama E; Suganuma A J Infect Chemother; 2012 Feb; 18(1):66-8. PubMed ID: 21809060 [TBL] [Abstract][Full Text] [Related]
9. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149 [TBL] [Abstract][Full Text] [Related]
10. Pre-exposure immunization against rabies using Japanese rabies vaccine following the WHO recommended schedule. Yanagisawa N; Takayama N; Nakayama E; Mannen K; Suganuma A J Infect Chemother; 2010 Feb; 16(1):38-41. PubMed ID: 20063031 [TBL] [Abstract][Full Text] [Related]
11. [A case received pre-exposure immunization against rabies by intradermal injection of rabies vaccine because of allergic reaction to the component of the vaccine]. Takayama N; Okuma K; Sakuma H Kansenshogaku Zasshi; 1999 Jun; 73(6):600-1. PubMed ID: 10423951 [TBL] [Abstract][Full Text] [Related]
12. Rabies post-exposure prophylactic vaccination for returning travelers to Japan. Yamamoto K; Ujiie M; Noguchi A; Kato Y; Fujiya Y; Mawatari M; Kutsuna S; Takeshita N; Hayakawa K; Kanagawa S; Inoue S; Morikawa S; Ohmagari N J Infect Chemother; 2019 Dec; 25(12):931-935. PubMed ID: 31155449 [TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India. Ashwath Narayana DH; Madhusudana SN; Sampath G; Tripathy RM; Sudarshan MK; Gangaboraiah ; Ravish HS; Satapathy DM; Gowda G; Holla R; Ashwin BY; Padhi A; Manjula S; Patel PM Hum Vaccin Immunother; 2014; 10(1):120-5. PubMed ID: 24030586 [TBL] [Abstract][Full Text] [Related]
14. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510 [TBL] [Abstract][Full Text] [Related]
15. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related]
16. Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis. Ravish HS; Vijayashankar V; Madhusudana SN; Sudarshan MK; Narayana DH; Andanaiah G; Ashwin BY; Rachana AR; Shamanna M Hum Vaccin Immunother; 2014; 10(8):2433-7. PubMed ID: 25424951 [TBL] [Abstract][Full Text] [Related]
17. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972 [TBL] [Abstract][Full Text] [Related]